Cidara Therapeutics Inc (CDTX)
20.40
+2.95
(+16.91%)
USD |
NASDAQ |
Nov 22, 16:00
21.31
+0.91
(+4.46%)
After-Hours: 20:00
Cidara Therapeutics Revenue (Annual): 63.90M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 63.90M |
December 31, 2022 | 64.45M |
December 31, 2021 | 49.57M |
Date | Value |
---|---|
December 31, 2020 | 12.07M |
December 31, 2019 | 20.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
12.07M
Minimum
2020
64.45M
Maximum
2022
42.18M
Average
49.57M
Median
2021
Revenue (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 2.419B |
Arbutus Biopharma Corp | 18.14M |
GlycoMimetics Inc | 0.01M |
FibroGen Inc | 147.75M |
Cue Biopharma Inc | 5.49M |